RxDoctor Payments Data

Martina Best, NP

Family · Ranson, WVNPI 1760050181

Payments from drug & device makers

$2,500in general payments, 2019–2025

Across 125 payments — averaging $20.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$470
  • Novo Nordisk$391
  • AstraZeneca$388
  • Bayer$355
  • AbbVie$331
  • GSK$127
  • plus $437 from 8 others

What the payments were for

  • Food & beverage$2,45598%
  • Education$452%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,500 in reported general payments places this provider in the 80th percentile of 1,507 family providers in West Virginia.

See all family providers in West Virginia

Medicare billing

Part B allowed, 2024
$42,037
Medicare patients
157
Services billed
467

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban36$52,335
JardianceEmpagliflozin29$38,085
OzempicSemaglutide32$36,419
MounjaroTirzepatide20$35,580
Trelegy ElliptaFluticasone/Umeclidin/Vilanter38$27,459
Breo ElliptaFluticasone/Vilanterol27$13,637
TrulicityDulaglutide12$13,199
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr16$7,519
SymbicortBudesonide/Formoterol Fumarate16$6,374
Lantus SolostarInsulin Glargine,hum.Rec.Anlog21$2,475
Albuterol Sulfate HfaAlbuterol Sulfate93$2,094
Atorvastatin Calcium225$1,775
Omeprazole102$1,423
Potassium Chloride27$1,415
Metoprolol Succinate105$1,316

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$116$52,33536 claims
Lilly USA, LLCMounjaro, Trulicity$470$48,77932 claims
GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta$127$48,61581 claims
Boehringer IngelheimJardiance$79$38,08529 claims
Novo NordiskOzempic$391$36,41932 claims
AstraZenecaSymbicort$388$6,37416 claims
AbbVieSynthroid$331$1,04313 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,507 family providers in West Virginia.

Other family in Ranson

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →